Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Vitamin D

What does the research say about Vitamin D?

13 health outcomes synthesised

Vitamin D is one of the most extensively researched supplements on Pillser, with structured evidence syntheses available for 13 health outcomes. The strongest and most consistent evidence supports its ability to increase 25-hydroxyvitamin D levels, based on 6 studies showing uniform benefit across elderly, children, and clinical populations. Doses in these studies ranged from 240 IU/day to 50,000 IU/week, though effect sizes varied widely, and the form of vitamin D (calcifediol vs. cholecalciferol) may influence efficacy.

Strongest evidence

The highest-confidence finding is for increased 25-hydroxyvitamin D levels (high evidence strength, 6 of 6 studies beneficial, mixed effect sizes). Moderate-strength evidence supports improvements in insulin sensitivity (5 of 6 studies beneficial, mixed effect sizes), reduced HOMA-IR (3 of 4 meta-analyses beneficial, small effects), reduced C-reactive protein (3 of 4 studies, moderate effects), and improved quality of life (4 of 4 studies, predominantly small effects). Doses across these moderate-strength outcomes were inconsistently reported but included 4000 IU/day and 60,000 IU/week where available.

Mixed or weaker evidence

Low-strength evidence is available for six outcomes, with mostly neutral or inconsistent results. Reduced inflammation in autoimmune arthritis populations showed small beneficial effects in all 4 studies, but the evidence base is small. Outcomes like reduced blood cholesterol, fasting blood glucose, BMI, triglycerides, LDL cholesterol, and systolic blood pressure each had 1-2 beneficial studies out of 3-4 total, with the majority showing neutral effects. The beneficial findings were often limited to specific clinical subgroups (e.g., MAFLD patients, obese youths with deficiency), limiting generalizability.

Effective dose patterns

No consistent effective dose emerged across outcomes. Where reported, daily doses ranged from 240 to 4000 IU/day, and weekly doses up to 50,000 IU. Most studies did not specify the form of vitamin D, though two syntheses noted that vitamin D2 (ergocalciferol) may differ from D3 (cholecalciferol) in efficacy for HOMA-IR and CRP reduction.

Population insights

Beneficial effects were most consistently observed in individuals with low baseline vitamin D levels (deficiency or insufficiency) and in clinical populations (diabetes, prediabetes, PCOS, MAFLD, autoimmune conditions). Effects in generally healthy or non-deficient populations were often neutral or smaller. Obese children and adolescents frequently showed neutral results across multiple metabolic outcomes.

Notable caveats

Publication bias is a recurring caveat — null-result studies may be under-indexed, especially for outcomes where all studies report benefit. The evidence base is small for most outcomes (3-6 studies each), and many syntheses note that co-supplementation with other nutrients (magnesium, vitamin E, Salacia reticulata) complicates attribution of effects to vitamin D alone. Dose and form reporting was inconsistent across studies, limiting practical dose-response conclusions.

Frequently asked

  • What is Vitamin D good for according to research?
    The strongest evidence supports vitamin D supplementation for increasing blood levels of 25-hydroxyvitamin D (6 of 6 studies, high evidence strength). Moderate evidence also shows benefits for improving insulin sensitivity (5 of 6 studies), reducing HOMA-IR (3 of 4 meta-analyses), lowering C-reactive protein (3 of 4 studies), and improving quality of life (4 of 4 studies), though effect sizes were small to moderate and primarily seen in clinical populations.
  • What dose of Vitamin D is typically used in studies?
    Doses varied widely across studies and were often not consistently reported. Where available, daily doses ranged from 240 IU to 4,000 IU, and weekly doses up to 50,000 IU. Study durations had a median of around 84-90 days where reported. No single dose emerged as consistently effective across all outcomes, and the form of vitamin D (D2 vs. D3) may influence results.
  • Who benefits most from Vitamin D supplementation?
    Research suggests that individuals with low baseline vitamin D levels (deficiency or insufficiency) and those with specific clinical conditions tend to benefit most. Beneficial effects were most frequently observed in patients with diabetes, prediabetes, PCOS, metabolic-associated fatty liver disease (MAFLD), and autoimmune conditions like rheumatoid arthritis. Effects in generally healthy or non-deficient populations were often neutral or smaller.
  • Are there caveats or limitations in the research on Vitamin D?
    Yes. Publication bias is frequently noted — studies with null results may be less likely to be published or indexed. The evidence base is small for most outcomes (3-6 studies each). Many studies used co-supplementation with other nutrients (magnesium, vitamin E), making it difficult to isolate vitamin D's effect. Dose and form reporting was inconsistent, limiting practical recommendations.
  • Does Vitamin D help with reducing inflammation?
    Moderate evidence from 4 studies (3 beneficial, 1 neutral) supports a modest anti-inflammatory effect measured by reduced C-reactive protein (CRP) in clinical populations (obese/overweight adults, diabetes/prediabetes). Low evidence from 4 studies in autoimmune arthritis populations (rheumatoid arthritis, psoriatic arthritis) also shows small beneficial effects on inflammation markers. Effects are modest and inconsistent.
  • Does Vitamin D help with weight loss or reducing cholesterol?
    The evidence does not support a clear effect. For BMI reduction, 3 of 4 studies found neutral effects, with benefit only seen in one study that combined vitamin D with another supplement. For cholesterol outcomes (total cholesterol, LDL), 3 of 4 meta-analyses found neutral effects, with small benefits limited to diabetes or MAFLD patients. Fasting blood glucose showed similar neutral results (3 of 4 studies neutral).

Most-studied combinations with Vitamin D

most supplement research is combination research
Also studied with:Beta-Alanine (2), Acetyl-Carnitine (2), Pomegranate (2), Resveratrol (2), Calcium (4), Zinc (5), Selenium (3), Magnesium (4), Lactobacillus rhamnosus GG (2), Protein (3), Vitamin A (4), Vitamin E (6)
  • Dr. Formulated Brain Health

    By Garden of Life

    4.5 (271 reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $26.59
    In
    Vitacost
    $26.59
    In
    Vitamin Shoppe
    $-
    Out
  • Women's Advanced Multivitamin

    By MegaFood

    4.7 (2K reviews)
    In Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $30.99
    In
    Vitacost
    $30.99
    In
    Vitamin Shoppe
    $-
    Out
  • Advanced Woman's Formula

    By Futurebiotics

    4.6 (1.4K reviews)
    In Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $16.45
    In
    Vitacost
    $-
    Out
    Vitamin Shoppe
    $-
    Out
  • Dr. Formulated Brain Health

    By Garden of Life

    4.5 (1.1K reviews)
    In Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $30.09
    In
    Vitacost
    $30.09
    In
    Vitamin Shoppe
    $-
    Out
  • Wild Norwegian

    By Carlson

    4.8 (1K reviews)
    In Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $42.42
    In
    Vitacost
    $-
    Out
    Vitamin Shoppe
    $-
    Out
  • Complete Food Multi

    By Trace Minerals

    5 (5 reviews)
    In Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $73.99
    In
    Vitacost
    $71.99
    In
    Vitamin Shoppe
    $-
    Out
Back to top